WASHINGTON — The biotech business’s largest commerce group has parted methods with its prime lobbyist, the group confirmed to STAT, including to a latest bout of organizational tumult.
The departure of Nick Shipley could also be a part of a better shake-up spearheaded by the Biotechnology Innovation Group’s new CEO, John Crowley, who took over in December. An electronic mail despatched to the group’s govt committee and obtained by STAT mentioned that Crowley is “contemplating structural modifications within the close to future which may impression whether or not or not the position is completely stuffed.”
Shipley’s final day as chief advocacy officer at BIO was Friday, and his profile has been faraway from the group’s web site. The departure was sudden, and he instantly packed up his workplace and left the constructing, based on three sources conversant in the departure.
